GlassScriptPhysician profile
Julie A Gavin
NPI 1700083276
$841.67
in general payments reported to CMS, 2019-2025
16 companies · $16.38 in 2025
The $16.38 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $62.25 · 2021: $72.63 · 2022: $187 · 2023: $233 · 2024: $111 · 2025: $16.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.07 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $299.82 | 2021-2024 | |
| Astellas Pharma US INC | $90.00 | 2023 | |
| Pfizer INC. | $80.57 | 2019-2022 | |
| Mckesson Patient Care Solutions INC. | $60.99 | 2019 | |
| Therapeuticsmd, INC. | $40.19 | 2019-2022 | |
| Abbvie INC. | $38.62 | 2019-2022 | |
| Novo Nordisk INC | $35.92 | 2023-2025 | Wegovy |
| Alfasigma USA, INC. | $31.93 | 2020 | |
| Allergan, INC. | $28.60 | 2019-2020 | |
| Daiichi Sankyo INC. | $25.99 | 2021-2022 | |
| Exact Sciences Corporation | $24.95 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $22.13 | 2022 | |
| Scynexis, INC. | $19.04 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.47 | 2020 | |
| Avion Pharmaceuticals | $13.43 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Gavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.